Pharmaceutical Executive, Mar 1, 2008 - Pharmaceutical Executive

ADVERTISEMENT
Pharmaceutical Executive, Mar 1, 2008
Features
4th Annual Press Audit: Coverage Uncovered!
By Stephen J. Porth , George P. Sillup
Pharma gets less ink as news reporters shift their sights to other topics? That's a good thing--Isn't it?
In Praise of Independence: Q&A with Roche's Dan Zabrowski
By Walter Armstrong
Roche has always gone its own way with biologics, deals, and new medicines. Now that the rest of industry has caught on, how can Roche stay ahead of its time?
Salesforce Roundtable
By Joanna Breitstein , Matthew Herman
Industry insiders explain how pharma companies are reorganizing their salesforces in the wake of industry-wide layoffs
Ad Stars 2008
By Sara Donnelly, Associate Editor , George Koroneos, Online Content & News Editor
Pharm Exec shines the spotlight on the creative innovators behind the best pharmaceutical ads of 2007
Washington Report
Open Season on FDA
By Jill Wechsler
Congress is firing plenty of ammunition at pharma companies—and the regulators
From the Editor
Come in Out of the Rain
By Patrick Clinton
For pharma to function, it needs a whole network that commands trust. The only alternative is the sort of regulation by mass tort that we've been sliding into in recent years
Global Report
Fire and NICE
By Sarah Houlton
UK agency takes the heat for slow evaluations and failing to consider societal benefits of new drugs
Commentary
Earning the Public Trust—and Keeping It
By Margaret Mueller, Leo J. Shapiro & Associates
The industry needs credibility with consumers to make a spoonful of risk go down. So how does pharma speak to top concerns?
Column
Are We Less Healthy Than Europeans?
By Humphrey Taylor
Americans take top spots in disease prevalence
Education Trumps Regulation
By James A. Dutton
New research points to the power of a highly educated sales force, supporting the case for a voluntary educational standard
Watch that Reputation
By Lisa Flaiz, Razorfish
Defending your brand through search optimization
The New Name of the Game: Adherence
By Andrée Bates
Why Big Pharma can no longer afford to treat patient adherence programs as an afterthought
Thought Leader
Study Rescue
By Kathleen Drennan
Pharma companies must quit wasting money and get strategic when mapping out their clinical study strategies
Technology
e-Pedigree to the Next Degree
By Peter Spellman, Supplyscape
Electronic pedigree is the future of supply chain security. Those still waiting and seeing might what to stop waiting and start tracking

ADVERTISEMENT

Click here